Salubritas Therapeutics
PrivateLast Round
Strategic
Dec 23, 2025
Company Overview
Salubritas Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Strategic round in December 2025.
Salubritas Therapeutics is a biotechnology company that develops regenerative therapies for hearing loss through sensory hair cell regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salubritas Therapeutics Comparables
Compare Salubritas Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Echogenesis Therapeutics | 83% | |
| AudioCure Pharma | 81% | |
| Rinri Therapeutics | 80% |
For institutional investors. Book with your work email.
Salubritas Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Salubritas Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shionogi & Co. | Strategic |
Salubritas Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Salubritas Therapeutics's valuation, stock price, and market status.
Is Salubritas Therapeutics a public or private company?
Salubritas Therapeutics is a private company.
What is the current stock price of Salubritas Therapeutics?
Salubritas Therapeutics is a private company, so its shares have no public market price. Caplight tracks Salubritas Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salubritas Therapeutics worth (valuation)?
Valuation information for Salubritas Therapeutics is not publicly available.
Can I buy Salubritas Therapeutics stock?
Salubritas Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salubritas Therapeutics's last funding round?
Salubritas Therapeutics's most recent funding round was Strategic on December 23, 2025.
Who are the main investors in Salubritas Therapeutics?
Key investors in Salubritas Therapeutics include Shionogi & Co..
Will Salubritas Therapeutics IPO soon?
No public IPO plans have been announced for Salubritas Therapeutics.
How can I track Salubritas Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Salubritas Therapeutics's shares on secondary markets.